Dabrafenib for treatment of BRAF-mutant melanoma

Por Kainthla, Radhika, Kim, Kevin B, Falchook, Gerald S
Publicado em 2013

Appearance of New Vemurafenib-associated Melanocytic Nevi on Normal-appearing Skin: Case Series and a Review of Changing or New Pigmented Lesions in Patients with Metastatic Malign...

Por Cohen, Philip R., Bedikian, Agop Y., Kim, Kevin B.
Publicado em 2013

Arginine deprivation therapy for malignant melanoma

Por Yoon, Jung-Ki, Frankel, Arthur E, Feun, Lynn G, Ekmekcioglu, Suhendan, Kim, Kevin B
Publicado em 2012

Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: a case report

Por Lee, Jee Min, Mehta, Urvi N., Dsouza, Ly H., Guadagnolo, B. Ashleigh, Sanders, Deborah L., Kim, Kevin B.
Publicado em 2013

Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report

Por Kim, Dae Won, Barcena, Edelyn, Mehta, Urvi N, Rohlfs, Michelle L, Kumar, Ashok J, Penas-Prado, Marta, Kim, Kevin B
Publicado no BMC Cancer (2015)

Immunohistochemical Expression of Hormone Receptors in Melanoma of Pregnant Women, Non-pregnant Women and Men

Por Zhou, Jane H., Kim, Kevin B., Myers, Jeffrey N., Fox, Patricia S., Ning, Jing, Bassett, Roland L., Hasanein, Hassan, Prieto, Victor G.
Publicado em 2014

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance

Por Wheler, Jennifer, Yelensky, Roman, Falchook, Gerald, Kim, Kevin B, Hwu, Patrick, Tsimberidou, Apostolia M, Stephens, Philip J, Hong, David, Cronin, Maureen T, Kurzrock, Razelle
Publicado no BMC Cancer (2015)

Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases

Por Alvarado, Gladys, Noor, Rahat, Bassett, Roland, Papadopoulos, Nicholas E., Kim, Kevin B., Hwu, Wen-Jen, Bedikian, Agop, Patel, Sapna, Hwu, Patrick, Davies, Michael A.
Publicado em 2012

A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors

Por LoRusso, Patricia M., Infante, Jeffrey R., Kim, Kevin B., Burris, Howard A., Curt, Gregory, Emeribe, Ugochi, Clemett, Delyth, Tomkinson, Helen K., Cohen, Roger B.
Publicado no BMC Cancer (2017)

Clinical Responses to Vemurafenib in Patients with Metastatic Papillary Thyroid Cancer Harboring BRAF(V600E) Mutation

Por Kim, Kevin B., Cabanillas, Maria E., Lazar, Alexander J., Williams, Michelle D., Sanders, Deborah L., Ilagan, Joseph L., Nolop, Keith, Lee, Richard J., Sherman, Steven I.
Publicado em 2013

Phase 1b study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanoma

Por Hong, David S., Kurzrock, Razelle, Falchook, Gerald S., Andresen, Corina, Kwak, Jennifer, Ren, Min, Xu, Lucy, George, Goldy C., Kim, Kevin B., Nguyen, Ly M., O'Brien, James P., Nemunaitis, John
Publicado no Oncotarget (2015)

Long term Survival with CTLA-4 blockade Using Tremelimumab

Por Eroglu, Zeynep, Kim, Dae Won, Wang, Xiaoyan, Camacho, Luis H., Chmielowski, Bartosz, Seja, Elizabeth, Villanueva, Arturo, Ruchalski, Kathleen, Glaspy, John A., Kim, Kevin B., Hwu, Wen-Jen, Ribas, Antoni
Publicado no Eur J Cancer (2015)

Changes in p-ERK1/2 and p-AKT Expression in Melanoma Lesions after Imatinib Treatment

Por Hwang, Cindy S., Prieto, Victor G., Diwan, Abdul H., Lizee, Gregory, Ellerhorst, Julie A., Ekmekcioglu, Suhendan, Liu, Ping, Eton, Omar, Kinney, Sandra A., Grimm, Elizabeth A., Hwu, Patrick, Kim, Kevin B.
Publicado em 2008

BRAF, NRAS, AND KIT SEQUENCING ANALYSIS OF SPINDLE CELL MELANOMA

Por Kim, Jinhyun, Lazar, Alexander J., Davies, Michael A., Homsi, Jade, Papadopoulos, Nicholas E., Hwu, Wen-jen, Bedikian, Agop Y., Woodman, Scott E., Patel, Sapna P., Hwu, Patrick, Kim, Kevin B.
Publicado em 2012

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Por Flaherty, Keith T., Puzanov, Igor, Kim, Kevin B., Ribas, Antoni, McArthur, Grant A., Sosman, Jeffrey A., O'Dwyer, Peter J., Lee, Richard J., Grippo, Joseph F., Nolop, Keith, Chapman, Paul B.
Publicado em 2010

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melano...

Por Alrwas, Anas, Papadopoulos, Nicholas E., Cain, Suzanne, Patel, Sapna P., Kim, Kevin B., Deburr, Tawania L., Bassett, Roland, Hwu, Wen-Jen, Bedikian, Agop Y., Davies, Michael A., Woodman, Scott E., Hwu, Patrick
Publicado no Melanoma Res (2014)

Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

Por Ott, Patrick A., Hamid, Omid, Pavlick, Anna C., Kluger, Harriet, Kim, Kevin B., Boasberg, Peter D., Simantov, Ronit, Crowley, Elizabeth, Green, Jennifer A., Hawthorne, Thomas, Davis, Thomas A., Sznol, Mario, Hwu, Patrick
Publicado no J Clin Oncol (2014)

Long-term outcome in BRAF(V600E) melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression

Por Puzanov, Igor, Amaravadi, Ravi K., McArthur, Grant A., Flaherty, Keith T., Chapman, Paul B., Sosman, Jeffrey A., Ribas, Antoni, Shackleton, Mark, Hwu, Patrick, Chmielowski, Bartosz, Nolop, Keith B., Lin, Paul S., Kim, Kevin B.
Publicado no Eur J Cancer (2015)

A Phase II Study of Gefitinib in Patients with Metastatic Melanoma

Por Patel, Sapna P., Kim, Kevin B., Papadopoulos, Nicholas E., Hwu, Wen-Jen, Hwu, Patrick, Prieto, Victor G., Bar-Eli, Menashe, Zigler, Maya, Dobroff, Andrey, Bronstein, Yulia, Bassett, Roland L., Vardeleon, Anna G., Bedikian, Agop Y.
Publicado em 2011

Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type

Por Torres-Cabala, Carlos A, Wang, Wei-Lien, Trent, Jonathan, Yang, Dan, Chen, Su, Galbincea, John, Kim, Kevin B, Woodman, Scott, Davies, Michael, Plaza, Jose A, Nash, JW, Prieto, Victor G, Lazar, Alexander J, Ivan, Doina
Publicado em 2009